SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Neurocrine Biosciences, Inc. Receives Approvable Letter For Indiplon Capsules And NON-Approvable For Indiplon Tablets For The Treatment Of Insomnia; Shares Plunge